NAN fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Nanosonics Ltd. engages in the provision of research, development, and commercialization of infection control and decontamination products and related technologies. It operates through the following geographical segments: North America, Europe and Middle East, and Asia Pacific. Its products include trophon EPR, trophon technology, and trophon2. The company was founded by Maurie Stang on November 14, 2000 and is headquartered in Sydney, Australia.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
NAN does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company